Vincent P. Clark (USA)
Professor of Psychology and Neuroscience, University of New Mexico
Dr. Vince Clark is Professor of Psychology and Neuroscience and Director of the Psychology Clinical Neuroscience Center at the University of New Mexico. He and his associates investigate the relationship between mind and brain. He employs structural and functional magnetic resonance imaging (fMRI), magnetoencephalography (MEG), event-related potentials (ERPs) and methods of transcranial brain stimulation, including transcranial direct current stimulation (tDCS) and transcranial alternating current stimulation (tACS), as well as other methods to examine human brain structure and function. Using these tools, he is investigating the basic organizational principles of perception, learning, memory, attention and language in healthy individuals. He also uses these methods to examine the neural basis of psychiatric disorders such as drug and gambling addiction, psychopathy and schizophrenia. His recent area of research examines how tDCS can be used to increase learning and performance in healthy subjects, and the mechanisms by which tDCS produces changes in brain function and behavior.
Felipe Fregni (USA)
Research Director at Spaulding Neuromodulation Center, Spaulding Rehabilitation Hospital
Associate Professor at Harvard T.H. Chan School of Public Health
Dr. Fregni's major research interests include the development of non-invasive brain stimulation techniques to understand and also to guide interventions aiming at modulating neuroplasticity in chronic neurological and neuropsychiatric conditions associated with maladaptive plasticity such as chronic pain and post-stroke motor rehabilitation. During his physician-scientist experience, Dr. Fregni has developed and conducted several clinical trials, as well as observational trials and even literature reviews on the subject. His contribution to science has given him the recognition of being a pioneer in transcranial electrical and magnetic stimulation. Additionally, Dr. Fregni's passion for scientific education and clinical research methodology cultured the biggest international worldwide training program in clinical research to allow young investigators from different countries and backgrounds to train in the Principles and Practice of Clinical Research course.
Satoru Otani (France)
INSERM researcher, Aging in Vision and Action Lab, Institute of Vision, CNRS-INSERM-Sorbonne University
Satoru Otani is a permanent researcher of INSERM (French national institute of health and medical research), working in Institute of Vision, Sorbonne University. His main interest is cellular and molecular mechanisms of long-term synaptic plasticity in the prefrontal cortex. He particularly studied how dopamine regulates synaptic plasticity in rodent prefrontal cortex. Currently, he also studies age- and stress-related cognitive declines/dysfunctions in rodents, as well as human high-order cognitive function from social neuroscience perspectives. He received his Ph.D. from University of Otago, New Zealand, in 1989. After post-doctoral studies in France and USA, he acquired the INSERM position in 1997 and worked as a group leader in Neuroscience Institute of University of Paris 6 (-2012). After working as a university professor in Japan (2012-2018), he rejoined INSERM. He also acts as an executive organizer of Japan-France Biological Society.
Adam J Woods (USA)
Center for Cognitive Aging and Memory, McKnight Brain Institute, University of Florida
Dr. Adam J. Woods is an Associate Professor of Clinical and Health Psychology and Assistant Director of the Center for Cognitive Aging and Memory (CAM) in the McKnight Brain Institute at the University of Florida. Dr. Woods is an interventional cognitive neuroscientist that focuses on discovery and application of novel non-invasive interventions for remediating age-related cognitive decline and preventing dementia. His work leverages non-invasive brain stimulation, multimodal neuroimaging and other clinical/cognitive neuroscience methods to not only evaluate the efficacy of promising brain-based interventions, but also understand their neural mechanisms. At present, Dr. Woods’ lab leads the first and largest ongoing Phase III tDCS clinical trial (the ACT study), as well as the largest ongoing near-infrared photobiomodulation Phase II trial (the Revitalize study). His ongoing work seeks to leverage multimodal neuroimaging, computational modeling, and machine learning to develop personalized dosing applications for enhanced efficacy of these methods in clinical applications.